Depression Treatment Studies: At the Depression Clinical and Research Program, the following treatment studies are currently under way, and seeking participants.
The DCRP is currently conducting cutting edge research in the area of depression, with a focus on testing novel antidepressant treatments and on developing new tools to understand the biological changes that occur in this condition.
If any of these studies interest you, please call us at 1-877-552-5837.
Group Treatment for Spanish-Speaking Patients with Diabetes
This study is investigating whether a group treatment using elements of support, problem-solving treatment and information can help improve diabetes outcomes and well-being in Spanish-speaking patients with diabetes. READ MORE
Tratamiento Grupal para Pacientes de habla Hispana con Diabetes Tipo II
Este estudio está investigando si un tratamiento grupal que usa elementos de apoyo, y tratamiento e información para la resolución de problemas puede ayudar a mejorar el pronóstico de la diabetes y el bienestar en pacientes de habla hispana con Diabetes Tipo II. READ MORE
A Study of Riluzole When Taken with Sertraline for Major Depressive Disorder:
The purpose of this study is to test whether adding the medication riluzole to Selective Serotonin Reuptake inhibitor (SSRIs) antidepressants for the treatment of depression enhances the efficacy of the SSRIs. READ MORE
Exploring biomarkers for depression:
This study looks at the biomarkers in voice, physiological, movement and brain imaging signals of patients with depression to investigate what types of biological signals identify and predict depression. READ MORE
Dialectical Behavior Therapy (DBT) for Patients with Depression and Suicidal Thoughts and Behaviors:
This is a study to see if a type of group therapy that teaches Dialectical Behavior Therapy (DBT) skills is helpful in treating symptoms of depression and suicidal thoughts and behaviors. READ MORE
Transcranial LED Light Therapy for Depression:
In this pilot study, we are testing whether Transcranial Laser Therapy (TLT) can help people’s depression. TLT involves a non-invasive and invisible beam of light that is briefly delivered to the forehead. TLT increases certain kinds of brain activity that may be useful for depression treatment.READ MORE
A Study of Iloperidone to Treat Anger and Irritability When Taken with an Antidepressant:
This study is investigating whether adding the medication Iloperidone to Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants will help treat symptoms of anger and irritability.
Ketamine Infusion for Treatment-resistant Major Depressive Disorder with Suicidal Ideation:
The purpose of this study is to test whether repeated use of intravenous ketamine, in addition to ongoing antidepressant treatment, improves symptoms of depression and suicidal ideation in patients who have not improved adequately on different antidepressant medication.
Help for sadness and excessive drinking in college students:
In this study, we are investigating new and effective therapy treatments for college students who experience depressive symptoms and drink excessively. We are comparing two different treatment courses, both of which consist of 8 sessions with a counselor and are provided at no cost. Participants will be compensated for their time.
Please note: This study is only open for targeted populations.
Comparison of Illness Beliefs of Depressed Caucasian and Chinese American Individuals
This is a study to learn about how depressed people from different cultural backgrounds understand their symptoms. READ MORE
Neural and Genetic Basis of Negative Valence Traits
The purpose of this study is to advance our understanding of how behavior, genes, and the brain contribute to anxiety and difficulties that people with anxiety often experience. To do this, we are looking at brain imaging and genetic differences in people with and without anxiety symptoms. READ MORE
Cortical GABA (Gamma-AminoButyric Acid) in MDD (Major Depressive Disorder)/Insomnia Study:
The purpose of this study is to understand the neurochemical mechanisms underlying insomnia in individuals with and without depression. We will assess a group with no insomnia and no depression, a group with insomnia without depression, a group with depression without insomnia and a group with depression and insomnia. In this way, we hope to determine whether GABA abnormalities in MDD are related to insomnia or the mood state. READ MORE
National Network of Depression Centers’ Clinical Care Registry:
In this research study, we are helping to form the first-ever national database on depression symptoms and treatment outcomes. Both research and clinical patients can take part in this study, by filling out questionnaires on their mood during their visits to the DCRP.